Orchard Therapeutics Overview

  • Founded
  • 2015

Founded
  • Status
  • Public

  • Employees
  • 259

Employees
  • Stock Symbol
  • ORTX

Stock Symbol
  • Investments
  • 1

  • Share Price
  • $0.45

  • (As of Monday Closing)

Orchard Therapeutics General Information

Description

Orchard Therapeutics PLC is a United Kingdom-based commercial-stage, a fully-integrated biopharmaceutical company. The company is engaged in transforming the lives of patients with serious and life-threatening rare diseases through autologous ex vivo gene therapies. It operates in three geographic regions: the United Kingdom, European Union, and the United States. Orchard Rx is focusing on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, used for the treatment of ADA-SCID five lentiviral product candidates.

Contact Information

Formerly Known As
Newincco 1387, Orchard Rx
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • 245 Hammersmith Road
  • 3rd Floor
  • London W6 8PW
  • England, United Kingdom
+44 020 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Orchard Therapeutics Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.45 $0.46 $0.41 - $1.55 $58.3M 127M 315K -$1.41

Orchard Therapeutics Financials Summary

In Thousands,
USD
TTM 30-Sep-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV (47,770) (27,641) 279,063 985,570
Revenue 16,152 1,675 2,595 2,513
EBITDA (175,470) (139,344) (151,563) (169,811)
Net Income (179,125) (144,584) (151,979) (163,422)
Total Assets 234,050 322,409 280,937 399,281
Total Debt 58,453 59,485 58,167 45,911
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Orchard Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Orchard Therapeutics‘s full profile, request access.

Request a free trial

Orchard Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Orchard Therapeutics‘s full profile, request access.

Request a free trial

Orchard Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Orchard Therapeutics PLC is a United Kingdom-based commercial-stage, a fully-integrated biopharmaceutical company. The c
Drug Discovery
London, United Kingdom
259 As of 2021
00000
000000000 00000

000000

do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostru
0000000000000
Gaithersburg, MD
00 As of 0000
00000
0000 0000-00-00
00000000 00000

000000

rud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in r
0000000000000
Plymouth Meeting, PA
000 As of 0000
000.00
00000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Orchard Therapeutics Competitors (86)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NexImmune Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
000000 00000000000 Corporation Plymouth Meeting, PA 000 000.00 00000000 000.00
00000000 000000000 Formerly VC-backed San Diego, CA 000 00000 000000000 - 00000
00000000 Formerly VC-backed Paris, France 00 000.00 000000000 000.00
00000000 Formerly VC-backed Mainz, Germany 0000 00.000 00000000 00.000
You’re viewing 5 of 86 competitors. Get the full list »

Orchard Therapeutics Patents

Orchard Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220370509-A1 Compositions and methods for treating or preventing crohn's disease Pending 12-Nov-2019 00000000000
CA-3160799-A1 Compositions and methods for treating or preventing crohn's disease Pending 12-Nov-2019 0000000000
EP-4058043-A1 Compositions and methods for treating or preventing crohn's disease Pending 12-Nov-2019 0000000000
AU-2020383510-A1 Compositions and methods for treating or preventing crohn's disease Pending 12-Nov-2019 0000000000
CA-3157966-A1 Compositions and methods for modifying eukaryotic cells Pending 16-Oct-2019 C08G65/08
To view Orchard Therapeutics’s complete patent history, request access »

Orchard Therapeutics Executive Team (20)

Name Title Board Seat Contact Info
Hubert Gaspar Chief Executive Officer & Board Member
John Cerio Chief Human Resources Officer
John Ilett Chief Legal Officer, Chief of Staff & Company Secretary
Fulvio Mavilio Ph.D Chief Scientific Officer
Nicolas Koebel Company Founder, GM France, Benelux, DACH & NORDICS
You’re viewing 5 of 20 executive team members. Get the full list »

Orchard Therapeutics Board Members (14)

Name Representing Role Since
Alicia Secor Self Board Member 000 0000
Charles Rowland Jr. Self Board Member 000 0000
Hubert Gaspar Orchard Therapeutics Chief Executive Officer & Board Member 000 0000
James Geraghty JD Self Chairman & Board Member 000 0000
Joanne Beck Ph.D Self Board Member 000 0000
You’re viewing 5 of 14 board members. Get the full list »

Orchard Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Orchard Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Orchard Therapeutics‘s full profile, request access.

Request a free trial

Orchard Therapeutics Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000000 12-Apr-2018 000000000 Buildings and Property 0000 0000
To view Orchard Therapeutics’s complete investments history, request access »